BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 25944758)

  • 1. Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the US melody valve investigational device exemption trial.
    Cheatham JP; Hellenbrand WE; Zahn EM; Jones TK; Berman DP; Vincent JA; McElhinney DB
    Circulation; 2015 Jun; 131(22):1960-70. PubMed ID: 25944758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year follow-up of the Melody transcatheter pulmonary valve multicenter post-approval study.
    Armstrong AK; Balzer DT; Cabalka AK; Gray RG; Javois AJ; Moore JW; Rome JJ; Turner DR; Zellers TM; Kreutzer J
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1254-62. PubMed ID: 25459038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient-related and procedural risk factors in the US Melody Valve Trial.
    McElhinney DB; Cheatham JP; Jones TK; Lock JE; Vincent JA; Zahn EM; Hellenbrand WE
    Circ Cardiovasc Interv; 2011 Dec; 4(6):602-14. PubMed ID: 22075927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial.
    McElhinney DB; Hellenbrand WE; Zahn EM; Jones TK; Cheatham JP; Lock JE; Vincent JA
    Circulation; 2010 Aug; 122(5):507-16. PubMed ID: 20644013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes After Transcatheter Reintervention for Dysfunction of a Previously Implanted Transcatheter Pulmonary Valve.
    Shahanavaz S; Berger F; Jones TK; Kreutzer J; Vincent JA; Eicken A; Bergersen L; Rome JJ; Zahn E; Søndergaard L; Cheatham JP; Weng S; Balzer D; McElhinney D
    JACC Cardiovasc Interv; 2020 Jul; 13(13):1529-1540. PubMed ID: 32646693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Outcomes After Melody Transcatheter Pulmonary Valve Replacement in the US Investigational Device Exemption Trial.
    Jones TK; McElhinney DB; Vincent JA; Hellenbrand WE; Cheatham JP; Berman DP; Zahn EM; Khan DM; Rhodes JF; Weng S; Bergersen LJ
    Circ Cardiovasc Interv; 2022 Jan; 15(1):e010852. PubMed ID: 34930015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocarditis After Transcatheter Pulmonary Valve Replacement.
    McElhinney DB; Sondergaard L; Armstrong AK; Bergersen L; Padera RF; Balzer DT; Lung TH; Berger F; Zahn EM; Gray RG; Hellenbrand WE; Kreutzer J; Eicken A; Jones TK; Ewert P
    J Am Coll Cardiol; 2018 Dec; 72(22):2717-2728. PubMed ID: 30497557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European studies.
    McElhinney DB; Benson LN; Eicken A; Kreutzer J; Padera RF; Zahn EM
    Circ Cardiovasc Interv; 2013 Jun; 6(3):292-300. PubMed ID: 23735475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of transcatheter pulmonary valve replacement on biventricular strain and synchrony assessed by cardiac magnetic resonance feature tracking.
    Harrild DM; Marcus E; Hasan B; Alexander ME; Powell AJ; Geva T; McElhinney DB
    Circ Cardiovasc Interv; 2013 Dec; 6(6):680-7. PubMed ID: 24300136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter Pulmonary Valve Replacement for Right Ventricular Outflow Tract Conduit Dysfunction After the Ross Procedure.
    Gillespie MJ; McElhinney DB; Kreutzer J; Hellenbrand WE; El-Said H; Ewert P; Rhodes JF; Søndergaard L; Jones TK
    Ann Thorac Surg; 2015 Sep; 100(3):996-1002; discussion 1002-3. PubMed ID: 26190388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and short-term outcomes of percutaneous transcatheter pulmonary valve replacement in small (<30 kg) children with dysfunctional right ventricular outflow tract conduits.
    Berman DP; McElhinney DB; Vincent JA; Hellenbrand WE; Zahn EM
    Circ Cardiovasc Interv; 2014 Apr; 7(2):142-8. PubMed ID: 24569596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-Year Outcomes From the Harmony Native Outflow Tract Early Feasibility Study.
    Benson LN; Gillespie MJ; Bergersen L; Cheatham SL; Hor KN; Horlick EM; Weng S; McHenry BT; Osten MD; Powell AJ; Cheatham JP
    Circ Cardiovasc Interv; 2020 Jan; 13(1):e008320. PubMed ID: 32525412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes Following Melody Transcatheter Pulmonary Valve Implantation for Right Ventricular Outflow Tract Dysfunction in Repaired Congenital Heart Disease: First Reported Australian Single Centre Experience.
    Markham R; Challa A; Kyranis S; Nicolae M; Murdoch D; Savage M; Malpas T; Radford DJ; Hamilton-Craig C; Walters DL
    Heart Lung Circ; 2017 Oct; 26(10):1085-1093. PubMed ID: 28185817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiopulmonary exercise function among patients undergoing transcatheter pulmonary valve implantation in the US Melody valve investigational trial.
    Batra AS; McElhinney DB; Wang W; Zakheim R; Garofano RP; Daniels C; Yung D; Cooper DM; Rhodes J
    Am Heart J; 2012 Feb; 163(2):280-7. PubMed ID: 22305848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter pulmonary valve replacement using the melody valve for treatment of dysfunctional surgical bioprostheses: A multicenter study.
    Cabalka AK; Asnes JD; Balzer DT; Cheatham JP; Gillespie MJ; Jones TK; Justino H; Kim DW; Lung TH; Turner DR; McElhinney DB
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1712-1724.e1. PubMed ID: 29395214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and performance of the Melody Transcatheter Pulmonary Valve in native and postsurgical, nonconduit right ventricular outflow tracts.
    Meadows JJ; Moore PM; Berman DP; Cheatham JP; Cheatham SL; Porras D; Gillespie MJ; Rome JJ; Zahn EM; McElhinney DB
    Circ Cardiovasc Interv; 2014 Jun; 7(3):374-80. PubMed ID: 24867892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position From the COMPASSION Multicenter Clinical Trial.
    Kenny D; Rhodes JF; Fleming GA; Kar S; Zahn EM; Vincent J; Shirali GS; Gorelick J; Fogel MA; Fahey JT; Kim DW; Babaliaros VC; Armstrong AK; Hijazi ZM
    JACC Cardiovasc Interv; 2018 Oct; 11(19):1920-1929. PubMed ID: 30286853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NuMED Covered Cheatham-Platinum Stent™ for the treatment or prevention of right ventricular outflow tract conduit disruption during transcatheter pulmonary valve replacement.
    Bishnoi RN; Jones TK; Kreutzer J; Ringel RE
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):421-7. PubMed ID: 25257401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter by Philip Regarding Articles, "Clinical and Hemodynamic Outcomes up to 7 Years After Transcatheter Pulmonary Valve Replacement in the US Melody Valve Investigational Device Exemption Trial" and "Pediatric Transcatheter Valve Replacement: Guests at Our Own Table?".
    Philip F
    Circulation; 2016 Jan; 133(2):e21. PubMed ID: 27028441
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationships Among Conduit Type, Pre-Stenting, and Outcomes in Patients Undergoing Transcatheter Pulmonary Valve Replacement in the Prospective North American and European Melody Valve Trials.
    Cabalka AK; Hellenbrand WE; Eicken A; Kreutzer J; Gray RG; Bergersen L; Berger F; Armstrong AK; Cheatham JP; Zahn EM; McElhinney DB
    JACC Cardiovasc Interv; 2017 Sep; 10(17):1746-1759. PubMed ID: 28823778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.